Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.320
+0.070 (1.65%)
At close: Jul 30, 2026, 4:00 PM EDT
4.330
+0.010 (0.23%)
After-hours: Jul 30, 2026, 7:48 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $26.73 million as of July 30, 2026. Its market cap has decreased by -45.62% in one year.
Market Cap
26.73M
Enterprise Value
-23.82M
1-Year Change
-45.62%
Ranking
Category
Stock Price
$4.32
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $26.73M, a decrease of -95.17%. That is a compound annual growth rate of -40.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 26.73M | -53.39% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 30.67M |
| BriaCell Therapeutics | 29.82M |
| Kyntra Bio | 27.45M |
| Actinium Pharmaceuticals | 26.26M |
| Actuate Therapeutics | 25.84M |
| ABVC BioPharma | 25.52M |
| Tevogen Bio Holdings | 25.06M |
| Plus Therapeutics | 24.99M |